Header cover image

U.K. Pharmaceuticals & Biotech Breakout Stocks

Results

1

1 new

Stocks where the price continues to rise after more than a year of consistent gains.

1 companies

Poolbeg Pharma

Market Cap: UK£55.0m

A clinical-stage biopharmaceutical company, engages in developing immunotherapy for cancer in the United Kingdom.

New

POLB

UK£0.083

7D

31.7%

1Y

225.5%